Ladenheim Dialysis Access Center — Fresno, California

Ladenheim Dialysis Access Center is a clinical research site located in Fresno, California, United States 93710.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Ladenheim Dialysis Access Center has participated in 4 clinical trials.

Therapeutic areas: Arteriovenous Graft, Chronic Kidney Disease, Renal Failure.

Sponsors: Shire, Proteon Therapeutics, Humacyte, Inc..

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ladenheim Dialysis Access Center?

Ladenheim Dialysis Access Center has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ladenheim Dialysis Access Center conducted?

Ladenheim Dialysis Access Center has 4 clinical trials on record. Their work covers Arteriovenous Graft, Chronic Kidney Disease, Renal Failure.

Is Ladenheim Dialysis Access Center accredited by Crixeo Health?

Ladenheim Dialysis Access Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ladenheim Dialysis Access Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.